好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Correlation Between Motor Progression and Structural Connectivity in GBA, LRRK2, and sporadic Parkinson’s Disease
Movement Disorders
S42 - Movement Disorders: Genetics and Risk Modifiers (4:18 PM-4:30 PM)
005
To examine longitudinal structural connectivity changes and their correlation to motor symptom progression in people with GBA, LRRK2, or sporadic Parkinson’s disease (PD).
Monogenetic forms of PD account for 5-10% of PD populations. Compared to LRRK2-related and sporadic PD, GBA-related PD patients have more severe motor symptoms and are at greater risk of developing dementia. We hypothesize differences in motor progression between PD cohorts are associated with changes in structural connectivity.
Data were accessed from the Parkinson’s Progressive Markers Initiative (PPMI) project. Subjects were divided into three cohorts: GBA, LRRK2, and sporadic PD (control). Longitudinal connectometry analyses were carried out at baseline, 24 and 48 months, correcting for age, sex, and mean DaTscan striatal binding. We investigated the correlation between white matter tract structural changes, as measured by quantitative anisotropy (QA), and changes in motor symptoms, as measured by Movement Disorders Society-Unified Parkinson’s Rating Scale Part III (MDS-UPDRS III).
There was a negative correlation between QA of the corpus callosum and corticothalamic tracts and MDS-UPDRS III score in GBA cohorts at 24 (n=11, FDR = 0.0007) and 48 months (n=12, FDR=0.007). The LRRK2 cohorts showed a negative correlation between QA of the corpus callosum, corticospinal, and parietopontine tracts and the MDS-UPDRS III at 48 months only (n=18, FDR=0.025). There were no significant associations in the sporadic cohorts.

Worsening motor impairment is associated with a decline in structural connectivity in select white matter tracts in GBA-related and LRRK2-related PD, which was not seen in the sporadic PD cohorts. These findings suggest a selective vulnerability of white tracts in monogenic forms of PD.
Authors/Disclosures
Cherry Yu, MD (Vanderbilt University Department of Neurology)
PRESENTER 		Dr. Yu has nothing to disclose.
No disclosure on file
Federico J. Rodriguez-Porcel, MD, FAAN (Medical University of South Carolina) Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Christine Cooper, MD (MUSC) Dr. Cooper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Cooper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Cooper has received research support from Biogen. The institution of Dr. Cooper has received research support from Abbvie. The institution of Dr. Cooper has received research support from NIH.